Home
News
News archive
Diamond Information


home > news FDA approves ketamine-like nasal spray for depression

FDA approves ketamine-like nasal spray for depression




The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.



Click Here to read the entire article...



Find this article in Google